MADRID, June 2, 2010 /PRNewswire/ -- Zimmer Holdings, Inc. , a leader in musculoskeletal care, today announced its presentation schedule for the 11th annual EFORT (European Federation of National Associations of Orthopaedics and Traumatology) Congress, highlighting advancements in its Reconstructive and Trauma offerings. Zimmer will be presenting three side events throughout the EFORT Congress to be held June 2-5, 2010 in Madrid, Spain.

Recon Innovations in the New Decade will introduce European surgeons to the latest Zimmer Reconstructive products. The discussion will focus on: Trabecular Metal(TM) Technology in Knee revisions; the Fitmore(R) Hip Stem, whose three different stem families and four offset options provide for a more accurate reconstruction of patient anatomy; and a presentation focused on Shoulder Systems. This session will be held on June 2.

On June 3, Integrated Taper Cup Systems will include a discussion of the recently launched Allofit(R) IT, Continuum(TM) and Trilogy(R) IT Acetabular Systems, all of which incorporate proven fixation technologies and an integrated taper design to give surgeons a wide range of advanced bearing options to better match the demands of individual patients.

Zimmer's third presentation, Zimmer Natural Nail, will introduce attendees to the Zimmer(R) Natural Nail(TM) System through a demonstration and discussion. The Zimmer Natural Nail System is a next-generation line of intramedullary nails, screws, instruments and other associated implants designed to provide stable fixation for long bone fractures and help restore the shape of fractured bone to its natural, pre-injured state. The session will be held on June 4.

The new Zimmer Natural Nail portfolio will not only be presented at the side event, but can also be seen at the Zimmer booth. Zimmer will also be highlighting the performance of its Zimmer(R) NexGen(R) Primary Knees, which have outranked other primary knee implants(1) in the Swedish Knee Arthroplasty Registry in the last consecutive five annual reports covering 14 years of revision data. The full Integrated Taper Cup Systems Portfolio will also be presented at the booth. The newly available enhanced instruments for Zimmer's Anatomical Shoulder(TM) System, which are designed for optimal ease of use and precision, are available as well.

The EFORT Congress is the ideal platform to spotlight the latest developments in Zimmer Reconstructive and Trauma products to European surgeons and we're particularly excited about this year's presentation schedule, said Katarzyna Mazur, Senior Vice President, Sales and Marketing, EMEA and General Manager, Zimmer GmbH. These presentations are also a great forum for interacting with surgeons. Zimmer seeks and welcomes feedback from the surgeon community to help improve our products and offer patients the best in musculoskeletal care.

The 11th EFORT Congress will be held in association with the Spanish Orthopaedic and Traumatology Society (SECOT) and will include symposia and instructional lectures as well as industry and technical presentations covering a range of contemporary orthopaedic and traumatology trends.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2009 sales were approximately US$4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

(1) The Swedish Knee Arthroplasty Register - Annual Report - Dept. of Orthopedics, Lund University Hospital: 2009 - ISBN 978-91-976020-9-9 - Page 30, 2008 - ISBN 978-91-976020-0-6 - Page 26, 2007 - ISBN 978-91-976019-5-5 - Page 24, 2006 - ISBN 91-976019-0-X (Swedish version) - Page 20, 2005 - Page 17

For more information about Zimmer, visit http://www.zimmer.com

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as may, will, expects, believes, anticipates, plans, estimates, projects, assumes, guides, targets, forecasts, and seeks or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE: Zimmer Holdings, Inc.

CONTACT: Media - Sabine Ciccotosto, +41 (0)52-262-72-41,sabine.ciccotosto@zimmer.com; or Paul Blair, +1-574-371-8042,paul.blair@zimmer.com; Investors - James T. Crines, +1-574-372-4264,james.crines@zimmer.com